Castle Creek Biosciences names new CEO
April 20, 2021 at 14:42 PM EDT
The company's lead gene therapy candidate is in late-stage clinical testing as a potential treatment for a rare skin disorder.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|